The State of Frontier Neuroscience: This is the century of the brain.
Why now, what’s investable & who wins.
External link. We are not responsible for the content.
Read more ↗More From PsyMed Ventures
Mariëlle van Kooten: Virtual Mitochondrial Models and the Case for Engineering Humans
Welcome back to Business Trip by PsyMed Ventures, a podcast exploring the future of mental health & wellness!
Brain Organoids: from Space to AI with Alysson Muotri
Professor Alysson R. Muotri (geneticist and developmental biologist at UC San Diego) joins for a far out conversation...
Digital Addiction: The Investment Landscape + What Wins Now
The first thing many of us touch in the morning is a screen. Checking notifications quickly turns into a scroll, the ...
Latest News
The Psychedelic Future We Were Promised
This Week's Sunday Insider: Why the Psychedelic Future Never Arrived.
Veterans Affairs continues to drive federal psychedelics push; New FDA guidance; and Resilient Pharmaceuticals tries again for MDMA approval
Plus: Pharmaceutical giant Eli Lilly makes a psychedelics acquisition; Cardiovascular safety is top of mind for psych...
9 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. Bestselling essayist & Psychedelic cultural analyst examining how altered states sha...
Puerto Rico Makes Moves on Ibogaine, MDMA, and Psilocybin
The island's governor just signed an executive order effectively launching a pilot program to research psychedelic th...
Microdosing for Anxiety: What the Evidence Shows, and Where It Doesn’t
Microdosing for anxiety looks encouraging in open-label surveys and far less convincing under placebo control. What f...
The Toads Didn’t Consent to Being Milked, Sorry
Chasing "enlightenment" at the expense of desert toads is not the flex you think it is. [...] Read More... The post T...